PF-05280014: Clinical Trials

1 trial of PF-05280014, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Recruiting 1

Follow PF-05280014: new trials by email Literature Review of PF-05280014 trials Research Report on PF-05280014

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis
Copper Cu 64-DOTA-Trastuzumab, Magnetic Resonance Imaging, Positron Emission Tomography - Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma
Phase 4RecruitingCity of Hope Medical Center102022-12-212026-07-01

Conditions studied

Brain Neoplasms (1)  ·  Breast Neoplasms (1)

Sponsors

City of Hope Medical Center (1)

Countries

United States (1)

Top investigators

Joanne E Mortimer (1)

NIH funding

P30CA033572 (1)